Where the pharma and medical app community shapes its future
The last year has seen a seismic shift in the number of companies launching new apps onto the market. Big pharma are starting to launch these in their dozens to help them find new routes to market, capture valuable patient information and help them streamline their internal processes. Healthcare providers and payors are also leaping at the opportunity to use apps as told to help them reduce primary care costs and enable people to take control of their own healthcare.
Are you part of the app revolution or are you still sitting on the sidelines?
Since the successful launch of the Healthcare Apps Summit last year which saw the community ask the difficult questions in the first industry led event of its kind, we’ve been finding experts to ask the difficult questions including:
When does my app become a medical device?
How can I increase user engagement?
How do I ensure my app is easy to use and interoperable?
Check out our expert case study line up for a sneak peak at the case studies they'll provide including:
- Insight from Bayer Healthcare on the regulation you need to comply with plus potential amendments and changes taking place now and in the next few years
- The MHRA’s guidance on when an app becomes a medical device and the consequences this definition incurs
- NHS England’s approach to ensuring interoperability to allow data sharing and integration of processes
- How BUPA have developed an app focused on user centricity and why this is so important